Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6

Experimental Cell Research

Volumn 319, Issue 14, 2013, Pages 2216-2229

  Lin, Jen Tsun ^a,b,c   Wang, Jeng Yi ^d   Chen, Mu Kuan ^a,b   Chen, Hong Chang ^a   Chang, Tung Hao ^a,b,c   Su, Bi Wen ^a   Chang, Pey Jium ^e  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c FENG CHIA UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

CD44; Colon cancer; IL 6; Mesenchymal stem cells; Notch 1

Indexed keywords

HERMES ANTIGEN; INTERLEUKIN 6; MEMBRANE ANTIGEN; NOTCH1 RECEPTOR;

ADIPOCYTE; ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER GROWTH; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL ISOLATION; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRUCTURE; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; LUNG METASTASIS; MESENCHYMAL STEM CELL; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

MUS MUSCULUS;

EID: 84880740785     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.06.003     Document Type: Article

References (43)

1. Tse W.T., Pendleton J.D., Beye W.M. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
2. Pittenger M.F., Mackay A.M., Beck S.C. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Zuk P.A., Zhu M., Mizuno H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
4. Chamberlain G., Fox J., Ashton B. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 2007, 25:2739-2749.
5. Santamaria-Martíneza A., Barquineroa J., Barbosa-Desonglesa A. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. Exp. Cell Res. 2009, 315:3004-3013.
6. Lin T.M., Chang H.W., Wang K.H Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem. Biophys. Res. Commun. 2007, 361:883-889.
7. Gibbs C.P., Kukekovz V.J.K., Reith J.D. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 2005, 7:967-976.
8. Cao H., Xu W., Qian H., Zhu W., Yan Y., Zhou H. Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett. 2009, 274:61-71.
9. Ishii M., Koike C., Igarashi A. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem. Biophys. Res. Commun. 2005, 332:297-303.
10. Tsai R.Y., McKay R.D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 2002, 16:2991-3003.
11. Bea S., Tort F., Pinyol A., Puig M.X. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001, 61:2409-2412.
12. Roorda B.D., ter Elst A., Kamps W.A. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit. Rev. Oncol. Hematol. 2009, 69:187-198.
13. Hamada H., Kobune M., Nakamura K. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci. 2005, 96:149-155.
14. Hung S.C., Deng W.P., Yang W.K. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 2005, 11:7749-7756.
15. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 2000, 28:875-884.
16. Jiang R., Xu W., Zhu W. Histological type of oncogenity and expression of cell cycle genes in tumor cells from human mesenchymal stem cells. Oncol. Rep. 2006, 16:1021-1028.
17. Zhu W., Xu W., Jiang R. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp. Mol. Pathol. 2006, 80:267-274.
18. Karnoub A.E., Dash A.B., Vo A.P Mesenchymal stem cells with tumor stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
19. Prantl L., Muehlberg F. Adipose tissue-derived stem cells prostate tumor growth. Prostate 2010, 70:1709-1715.
20. Khakoo A.Y., Pati S., Anderson S.A. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 2006, 203:1235-1247.
21. Knüpfer H., Preiss R. Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Int. J. Colorectal. Dis. 2010, 25:135-140.
22. Schneider M.R., Hoeflich A., Fischer J.R., Wolf E., Sordat B., Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 2000, 151:31-38.
23. Hsu C.P., Chen Y.L., Huang C.C. Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. Eur. J. Clin. Invest. 2011, 41:277-284.
24. Miele L. Notch signaling. Clin. Cancer Res. 2006, 12:1074-1079.
25. Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat. Rev. Cancer 2011, 1:338-351.
26. Zhang Y., Li B., Ji Z.Z. Notch1 regulates the growth of human colon cancers. Cancer 2010, 116:5207-5218.
27. Gunthert U., Stauder R., Mayer B., Terpe H.J., Finke L., Friedrichs K. Are CD44 variant isoforms involved in human tumor progression?. Cancer Surv. 1995, 24:19-42.
28. Kuhn S., Koch M., Nubel T. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol. Cancer Res. 2007, 5:553-567.
29. Dalerba P., Dylla S.J., Park I.K. Phenotypic characterization of human colorectal cancer stem cells. Proc. Nat. Acad. Sci. U.S.A. 2007, 104:10158-10163.
30. Takaishi S., Okumura T., Tu S.P. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
31. Chen K.L, Pan F., Jiang H. Highly enriched CD133 (+) CD44 (+) stem-like cells with CD133 (+) CD44 (high) metastatic subset in HCT116 colon cancer cells. Clin. Exp. Metastais 2011, 13:275-280.
32. Haraguchi N., Ohkuma M., Sakashita H. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann. Surg. Oncol. 2008, 15:2927-2933.
33. Hwang W.L., Yang M.H., Tsai M.L., Lan H.Y., Su S.H., Chang S.C., Teng H.W., Yang S.H., Lan Y.T., Chiou S.H., Wang H.W. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011, 141:279-291.
34. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J. Prospective identification of tumorigenic breast cancer cells. Proc. Nat. Acad. Sci.U.S.A. 2003, 100:3983-3998.
35. Pittenger M.F. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
36. Young H.E. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat. Rec. 2001, 264:51-62.
37. Mishra P.J., Humeniuk R., Medina D.J., Alexe G., Mesirov J.P,J.P., Ganesan S., Glod J.W., Banerjee D. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008, 68:4331-4339.
38. Shinagawa K., Kitadai Y., Tanaka M Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int. J. Cancer 2010, 127:2323-2333.
39. Quante M., Tu S.P., Tomita H., Gonda T., Wang S.S., Takashi S., Baik G.H., Shibata W., Diprete B., Betz K.S., Friedman R., Varro A., Tycko B., Wang T.C. Bone Marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011, 19:257-272.
40. Tsai K.S., Yang S.H., Lei Y.P., Tsai C.C., Chen H.W., Hsu C.Y., Chen L.L., Wang H.W., Miller S.A., Chiou S.H., Hung M.C., Hung S.C. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 2011, 141:1046-1056.
41. Gao H., Priebe W., Glod J., Banerjee D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009, 27:857-865.
42. Shinagawa K., Kitadai Y., Tanaka M., Sumida T., Onoyama M., Ohnishi M., Ohara E., Higashi Y., Tanaka S., Yasui W., Chayama K. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int. J. Cancer 2013, 132:813-823.
43. Hsu H.S., Lin J.H., Hsu T.W., Su K., Wang C.W., Yang K.Y., Chiou S.H., Hung S.C. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer 2012, 75:167-177.